Among the pathologies of the optic nerve optical neuritis occur in 30-40% of cases. Most researchers believe that 80% of patients it can be the first and sometimes the only manifestation of MS, while 13% of cases, it arises on the background of general clinics multiple sclerosis. Currently, multiple sclerosis is considered not only as a demyelinating disease of the central nervous system, but also as a neurodegenerative disease. The use of drugs with neurotrophic, antioxidant effect, which penetrate through the blood-brain border is an important component of the pathogenetic therapy of various lesions of the central nervous system, including multiple sclerosis. Unlike most diseases, patients with multiple sclerosis may be identified in the initial stages of the disease, which contributes to early onset and reduce the neurodegenerative processes that lead to progression of disease and disability patient.